Aytu BioPharma, Inc. - SIC # 2834 - PHARMACEUTICAL PREPARATIONS

Ticker Exchange SIC # Website Latest Ticker
AYTU Nasdaq 2834 aytubio.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Aytu BioPharma, Inc.

Aytu BioPharma Third Quarter 2025 Earnings: Beats Expectations - May 16th, 2025 10:51 am
Aytu BioPharma Inc (AYTU) Q3 2025 Earnings Call Highlights: Strong Revenue Growth and ... - May 15th, 2025 7:17 am
Aytu BioPharma Reports Fiscal 2025 Third Quarter Operational and Financial Results - May 14th, 2025 8:05 pm
Aytu BioPharma to Report Fiscal 2025 Third Quarter Operational and Financial Results on May 14, 2025 - May 7th, 2025 8:15 pm
Aytu BioPharma to Present at the Planet MicroCap Showcase: VEGAS 2025 on April 23, 2025 - Apr 21st, 2025 8:05 pm
Loss-Making Aytu BioPharma, Inc. (NASDAQ:AYTU) Set To Breakeven - Feb 15th, 2025 2:36 pm
Aytu BioPharma Inc (AYTU) Q2 2025 Earnings Call Highlights: Strong Cash Position and Strategic ... - Feb 13th, 2025 1:00 pm
Aytu BioPharma Reports Fiscal 2025 Second Quarter Operational and Financial Results - Feb 12th, 2025 9:03 pm
Aytu BioPharma to Report Fiscal 2025 Second Quarter Operational and Financial Results on February 12, 2025 - Feb 5th, 2025 10:50 pm
Aytu BioPharma to Participate in the Lytham Partners 2025 Investor Healthcare Summit on January 13, 2025 - Jan 6th, 2025 2:00 pm
Aytu BioPharma Proposes Settlement in Shareholder Lawsuit - Dec 5th, 2024 11:32 am
Aytu BioPharma Disclosure Notification - Dec 4th, 2024 4:45 am
Aytu BioPharma Ranked as One of Fastest-Growing Companies in North America on the 2024 Deloitte Technology Fast 500(TM) - Nov 22nd, 2024 2:00 pm
Aytu BioPharma First Quarter 2025 Earnings: Beats Expectations - Nov 16th, 2024 1:31 pm
Aytu BioPharma Inc (AYTU) Q1 2025 Earnings Call Highlights: A Historic Quarter with Positive ... - Nov 14th, 2024 7:16 am
Aytu BioPharma Reports Fiscal 2025 First Quarter Operational and Financial Results - Nov 13th, 2024 9:05 pm
Aytu BioPharma to Report Fiscal 2025 First Quarter Operational and Financial Results on November 13, 2024 - Nov 6th, 2024 10:20 pm
Aytu BioPharma to Participate in the 2024 Maxim Healthcare Virtual Summit - Oct 14th, 2024 8:15 pm
Aytu BioPharma Announces Exclusive Agreement with Lupin Pharma Canada Ltd to Commercialize Adzenys XR-ODT(R) and Cotempla XR-ODT(R) in Canada - Oct 1st, 2024 12:00 pm
Aytu BioPharma Full Year 2024 Earnings: EPS Misses Expectations - Sep 28th, 2024 12:49 pm